Treatment of renal failure in patients with newly diagnosed multiple mieloma with bortezomib and dexamethasone: results of a phase II trial from PETHEMA/GEM group (RENVEL)
Clinical Lymphoma, Myeloma & Leukemia（2015）
Abstract
Bortezomib has shown significant activity in patients with renal failure (RF). We report here the results of a phase II trial for patients with newly diagnosed MM and RF treated with bortezomib and dexamethasone (VD).
MoreTranslated text
Key words
Novel Therapies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined